SNX-2112

SynDRA canonical compound SYN0019337 — structure-anchored drug synonym record

Clinical phase	Phase 1
Mechanism of action	HSP inhibitor

All known targets

HSP90AA1

Mechanisms of action (all sources)

HSP inhibitor
HSP90AA1 INHIBITOR

Cross-references

PubChem CID: 24772860
ChEMBL: CHEMBL560895
DrugBank: DB17055
PDB: E0G
TTD: D0K0TJ
LINCS BRD: BRD-K71281111

Synonyms

PF-04928473
SNX 2112
4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide
UNII-10C9P3FFOW
10C9P3FFOW
CHEMBL560895
SNX-2112 (PF-04928473)
4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide
4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(cis-4-hydroxycyclohexyl)amino]benzamide

Look up SNX-2112 in the interactive SynDRA portal →